Loading…
Fierce Biotech Next Gen 2023 has ended
avatar for Antoine Papiernik

Antoine Papiernik

Sofinnova Partners
Chairman and Managing Partner
Antoine Papiernik is Chairman and Managing Partner at Sofinnova Partners, which he joined in 1997. He has been an initial investor and active board member in a number of public companies, including Actelion, ProQR, Shockwave Medical, NovusPharma (sold to CTI), and Movetis (sold to Shire). Trade sale success stories include CoreValve (sold to Medtronic), Fovea (sold to Sanofi Aventis), Ethical Oncology Science (EOS, sold to Clovis Oncology) and Recor Medical (sold to Otsuka). He has also invested in and is a board member of private companies Reflexion Medical, Tissium, PiCardia, SafeHeal, Noema Therapeutics, May Health, Highlife and Inspirna (formerly Rgenix). Antoine has an MBA from the Wharton School of Business and has appeared twice on the Forbes Midas List. 

My Speakers Sessions

Tuesday, June 13
 

2:15pm EDT